Synthetic lincosamides iboxamycin and cresomycin are active against ocular multidrug-resistant methicillin-resistant Staphylococcus aureus carrying erm genes
Our results demonstrate that iboxamycin and cresomycin display potent in vitro activity against ocular MRSA isolates, including multidrug-resistant isolates harbouring erm genes.
Authors
- Paulo J. M. Bispo (ORCID: https://orcid.org/0000-0002-2867-1450)
- Kelvin J. Y. Wu (ORCID: https://orcid.org/0000-0002-5561-6369)
- Andrew G. Myers (ORCID: https://orcid.org/0000-0001-9602-6915)
- Camille André (ORCID: https://orcid.org/0000-0002-8461-8574)
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Harvard University (US)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1016/j.jgar.2024.09.001
- Citations
- 1
- Primary Topic
- Ocular Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Massachusetts Eye and Ear
- Massachusetts Lions Eye Research Fund
- Fondation pour la Recherche Médicale
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases